Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy Targeted Therapies to Reverse Resistance /
Patients with various cancers are treated with conventional chemotherapeutic drugs and the majority responds well to such therapies. However, there is a subset of patients who does not respond initially and another subset who no longer responds to further treatments. Clearly, in those two subsets of...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Σειρά: | Resistance to Targeted Anti-Cancer Therapeutics,
1 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Preface
- Multidrug resistance in cancer: a tale of ABC drug transporters
- Multidrug resistance: a role for membrane physics, pH and drug transporters
- Mechanisms and potential therapies for acquired resistance to inhibitors targeting the Raf or MEK kinases in cancer
- Mechanisms of resistance to targeted B-Raf therapies
- Role of β1integrins in the complication and drug resistance against lung cancer: targeting β1integrins to eradicate lung cancer
- Aldo-keto reductases as new therapeutic targets for colon cancer chemoresistance
- Overcoming drug resistance through elevation of ROS in cancer
- Cancer stem cells in resistance to cytotoxic drugs: implications in chemotherapy
- Two birds with a stone: molecular cancer therapy targeting signal transduction and DNA repair pathways
- Collateral sensitivity in drug-resistant tumor cells
- Human cancer resistance to trail-apoptotic pathway-targeted therapies
- The dark side of apoptosis
- Index.
